Effect of Amla fruit (Emblica officinalis Gaertn.) on blood glucose and lipid profile of normal subjects and type 2 diabetic patients

References

• Akhtar MS. 1982. Trials of Momordica charantia powder in patients with maturity onset diabetes: A preliminary report. J Pak Med Acad. 32:106–107.
   PubMedGoogle Scholar
• Akhtar MS. 1992. Hypoglycemic activities of some indigenous medicinal plants traditionally used as anti-diabetic drug. J Pak Med Acad. 42:271–277.
   PubMedGoogle Scholar
• Akhtar MS. 1995. Efficacy of some indigenous medicinal plants in diabetic patientsProceedings of the 2nd Annual National Symposium on Health Care and Social Development. Karachi, Pakistan: The Aga Khan University. 232–236.
   Google Scholar
• Akhtar MS, Ali MR. 1985. Study of hypoglycemic activity of Cuminum nigrum seeds in normal and alloxan-diabetic rabbits. Planta Med. 51:81–85.
   Google Scholar
• Akhtar MS, Akhtar MA, Yaqub M. 1981. Effect of Momordica charantia on blood glucose level of normal and alloxan diabetic rabbits. Planta Med. 42:205–212.
   PubMed Web of Science ®Google Scholar
• Aslokar L, Kakkar KK, Chakre OJ. Supplement to Glossary of Indian Medicinal Plants with Active Principles. New Delhi, India: Directorate of CSIR. 1992291–293.
   Google Scholar
• Asmawi MZ, Kankaanranta H, Moilanen R. 1993. Anti-inflammatory activities of Emblica officinalis Gaertn leaf extracts. J. Pharm Pharmacol. 45:581–584.
   PubMed Web of Science ®Google Scholar
• Broadhurst CL, Polansky MM, Anderson RA. 2000. Insulin like biological activity of culinary and medicinal plant extracts in-vitro. J Agric Food Chem. 48:849–852.
   PubMed Web of Science ®Google Scholar
• Davis SN. 2007. Management of type 2 diabetes mellitus with basal prandial insulin therapy: A case based review. Insulin. 2:118–126.
   Google Scholar
• Davis N, Forbes B, Wylie-Rosett J. 2009. Nutritional strategies in type 2 diabetes. Mount Sinai J Med. 76:257–268.
   PubMedGoogle Scholar
• Freeman JS. 2010. New therapeutic options: Management strategies to optimize glycemic control. J Am Osteopath Assoc 110(3 Suppl. 2):515–520.
   Google Scholar
• Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem. 18:499–502.
   PubMed Web of Science ®Google Scholar
• Garg AN, Kumar A, Nair AG, Reddy AVR. 2005. Determination of minor and trace elements in Trifla—A herbal preparation. J Radioanal Nucl Chem. 263:751–758.
   Web of Science ®Google Scholar
• Grundy SM. 1998. Dietary influence on serum lipids and cholesterol. J lipids Res. 31:1149–1172.
   Google Scholar
• Hassani-Ranjbar S, Nayebi N, Moradi L, Mehri A, Larijani B, Abdollahi M. 2010. The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia: A systematic review. Curr Pharmac Design. 16:2935–2947.
   PubMedGoogle Scholar
• Hazra B, Sarkar R, Biswas S, Mandal N. 2010. Comparative study of anti-oxidant and reactive oxygen speciesscavenging properties in the extracts of fruits of Terminalia chebula. Terminalia belerica and Emblica officinalis. BMC Complementary Alternative Med. 10:20.
   PubMed Web of Science ®Google Scholar
• He J, Klag MJ, Whelton PK, Mo JP, Chen JY, Qian MC, Mo PS, He GQ. 1995. Oat bran intake selectively lower serum LDL-C concentration of hypercholesterolemic men. Am J Clin Nutr. 61:366–372.
   PubMedGoogle Scholar
• Khan A, Safdar M, Khan MMA, Khattak KN, Anderson AR. 2003. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 26:3215–3218.
   PubMed Web of Science ®Google Scholar
• Kim HY, Okubo T, Juneja LJ, Yokozawa T. 2010. The protective role of Amla (Emblica officinalis Gaertn) against fructose-induced metabolic syndrome in a rat model. Br J Nutr. 103:502–512.
   PubMed Web of Science ®Google Scholar
• Kumar NJ, Loganathan P. 2010. Hypoglycemic effects of Spinacia oleracea in alloxan induced diabetic rats. Global J Biotech Biochem. 5:87–91.
   Google Scholar
• Laurence DR, Bacharach AL. Evaluation of Drug Activities: Pharmacometrics. London: Academic Press. 196433–35.
   Google Scholar
• Lewis HW, Elvin-Lewis MPH. Medical Botany: Plant Affecting Man's Health. New York: John Wiley and Sons. 1977217–218.
   Google Scholar
• Lopez-Virella MF. 1977. High density lipoprotein cholesterol estimation. Clin Chem. 23:882–884.
   PubMed Web of Science ®Google Scholar
• Lorgeril W. 1999. The medical consequences of high level of triglycerides. Exp Clin Endocrinol Diabetes. 106:1–6.
   Google Scholar
• Mand JK, Soni GL, Gupta PP, Singh R. 1991. Effect of Amla (Emblica officinalis) on the development of atherosclerosis on hypercholesteromic rabbits. Punjab Agric Univ Ludhiana J Res Edu. 10 2: 1–7.
   Google Scholar
• Mathur R, Sharma A, Dixit VP, Varma M. 1996. Hypolipidemia effect of fruit juice of Embilica officinalis in cholestrol-fed rabbits. J Ethnopharmacol. 50 2: 61–68.
   PubMedGoogle Scholar
• Morelli V, Zoorob RJ. 2000. Alternative therapies Part I. Depression, diabetes, obesity. Ann Farm Physician. 62:1051–1060.
   Google Scholar
• Mossihuzzaman M, Nahar N, Ali L. 1994. Hypoglycaemic effects of three plants form Eastern Himalayan belt. Diabetes Res. 26 3: 127–138.
   PubMedGoogle Scholar
• Mushtaq A, Almas K, Hashmi AS, Hussain SJ, Ahmad I. 2000. Alloxan induced diabetic rabbits. Effects of fibrous and non-fibrous diets on serum glucose and some lipid profile. Prof Med J. 7 3: 309–312.
   Google Scholar
• Muthuraman A, Sood S, Singla SK. 2010. The anti-inflammatory potential of phenolic compounds from Emblica officinalis L. in rats. Inflammopharmacology. Published online on 2nd July 2010. DOI 10.1007/s 10787-010-0041-9.
   Google Scholar
• Nampoothiri SV, Prathapan A, Cherian OL, Raghu KG, Venugopalan VV, Sunderasan A. 2010. In-vitro antioxidant and inhibitory potential of Terminalia bellerica and Emblica officinalis fruits against LDL oxidation and key enzymes linked to type 2 diabetes. Food Chem Toxicol. 49:125–130.
   PubMedGoogle Scholar
• O'Loughlin A, McIntosh C, Dinneen SF, O'Brien T. 2010. Basic concepts to novel therapies: A review of the diabetic foot. Int J Lower Extremity Wounds. 9:90–102.
   PubMed Web of Science ®Google Scholar
• Pederson O, Hermenson K, Palmvig B, Pederson SE, Sondergaard K. 1992. Dietary treatment of diabetes recommendations in 1990’s. Ugesker Lal ger. 154 14: 910–916.
   PubMedGoogle Scholar
• Perry LM. Medicinal Plants of East and South-East Asia: Attributed Properties and Uses. Cambridge, MA: MIT Press. 1980149–150.
   Google Scholar
• Rajagopal K, Sasikala K. 2008. Antihyperglycaemic and antihyperlipidemic effects of Nymphaea stellata in alloxan-induced diabetic rats. Singapore Med J. 49 2: 137–141.
   PubMedGoogle Scholar
• Rajarama-Rao MR, Siddiqui HH. 1964. Pharmacological studies on Emblica officinalis Gaertn. Indian Exp Biol. 2:29–31.
   Google Scholar
• Reddy VD, Padmavathi P, Kavitha G, Gopi S, Varadacharyulu N. 2010. Emblica officinalis ameliorates alcohol-induced brain mitochondrial dysfunction in rats. J Med Foods. 14:68–62.
   Google Scholar
• Richmond W. 1973. Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem. 19:1350–1356.
   PubMed Web of Science ®Google Scholar
• Robert S. 2002. Diabetes Self-management. New York: R.A. Rappaport Publishing Company.
   Google Scholar
• Sabu MC, Kuttan R. 2002. Anti-diabetic activities of medicinal plants and its relationship with their antioxidant properties. J Ethnopharmacol. 81:155–160.
   PubMed Web of Science ®Google Scholar
• Said M. Hamdard Pharmacopoeia of Eastern Medicine. Sadar Karachi, Pakistan: Time Press. 1969379.
   Google Scholar
• Satyavati GV, Raina MK, Sharma M. 1976. Medicinal Plants of India. New Delhi: Indian Council of Medical Research. 1:48–51.
   Google Scholar
• Scartezzini P, Antognoni F, Raggi MA, Poli F, Sabbioni C. 2006. Vitamin C content and antioxidant activity of the fruit and of the Ayurvedic prepration of Emblica officinalis Gaertn. J Ethnopharmacol. 104:113–118.
   PubMed Web of Science ®Google Scholar
• Sharma VK, Kumar S, Patel HJ, Hugar S. 2010. Hypoglycemic activity of Ficus glomerata in alloxan-induced diabetic rats. Int J Pharmac Sci Res. 1 2: 18–22.
   Google Scholar
• Sidhu S, Pandhi P, Malhotra S, Vaiphei K, Khanduja KL. 2010. Beneficial effects of Emblica officinalis in l-arginine induced acute pancreatitis in rats. J Med Food. 14:155–147.
   Google Scholar
• Steel RGD, Torrie JH, Dickey DA. 1997. Principles and Procedures of Statistics. A Biometrical Approach. New York: McGraw Hill Publishing Company.
   Google Scholar
• Vessby B, Karlstron B, Ohroal M, Jarvi A, Anderson A, Basil S. 2000. Diet, nutrition and diabetes mellitus. UPS J Med Sci. 105:151–160.
   PubMed Web of Science ®Google Scholar
• Vinik A. 2007. Advancing therapy in type 2 diabetes mellitus with early comprehensive progression from oral agents to insulin therapy. Clin Ther. 29:1236–1253.
   Web of Science ®Google Scholar
• World Health Organization. 2006. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a World Health Oranization (WHO) and International Diabetes Federation (IDF) Consultation. Geneva, Switzerland: WHO Document Publication Services.
   Google Scholar
• Zoeliner N, Kirsch K. 1962. Uber die quantitative Bestimmung von lipiden (mikromethode) mittels der vielen naturlischen lipiden (alle bekannten plasma lipiden) gemeinsamen sulfophosphovanillin reaktion. Z Gesamte Exp Med. 135:545–561.
   Google Scholar